Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-01-19 | Dr. Glimcher has served as a Professor of Microbiology and Immunology at Harvard Medical School since May 2017, the Richard and Susan Smith Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute since October 2016, an Attending Physician, Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute since October 2016, and the President and Chief Executive Officer of the Dana-Farber Cancer Institute since September 2016. ... Committee Membership(s): Compensation and Talent |
| 2025-01-27 | Dr. Glimcher has served as a Professor of Microbiology and Immunology at Harvard Medical School since May 2017, the Richard and Susan Smith Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute since October 2016, an Attending Physician, Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute since October 2016, and President Emerita of the Dana-Farber Cancer Institute since October 2024. |
| Filing Date | Source Excerpt |
|---|---|
| 2013-03-29 | Laurie H. Glimcher, M.D., 61, has served as a Director of the Company since January 1998. Dr. Glimcher is the Stephen and Suzanne Weiss Dean of the Weill Cornell Medical College. The Nominating and Corporate Governance Committee currently consists of Dr. Laurie H. Glimcher. Director compensation in 2012 was $295,630. |
| 2014-04-04 | Laurie H. Glimcher, M.D., 62, has served as a Director of the Company since January 1998. Dr. Glimcher is a Director of Bristol-Myers Squibb Company. The Nominating and Corporate Governance Committee currently consists of Dr. Laurie H. Glimcher. The director compensation table shows her total compensation as $296,825 for 2013. |
| 2015-04-01 | Laurie H. Glimcher, M.D., 63, has served as a Director of the Company since January 1998. ... The Nominating and Corporate Governance Committee currently consists of Dr. Michael J. Berendt (Chair), Dr. Laurie H. Glimcher, and Mr. Thomas P. Salice. |
| 2016-04-01 | Laurie H. Glimcher, M.D., 64, has served as a Director of the Company since January 1998. Dr. Glimcher is the Stephen and Suzanne Weiss Dean of the Weill Cornell Medical College and Provost for Medical Affairs of Cornell University. From 1991 through 2011, Dr. Glimcher served as the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School. Dr. Glimcher is a Director of Bristol-Myers Squibb Company. She is a Fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences and the Institutes of Medicine of the National Academy of Sciences. As a physician, scientist and professor, Dr. Glimcher brings a diversity of technical skills and experience to the Waters Board. The Nominating and Corporate Governance Committee currently consists of Dr. Michael J. Berendt (Chair), Dr. Laurie H. Glimcher, and Mr. Thomas P. Salice. |
| 2017-03-29 | Dr. Glimcher, 65, has served as a Director of the Company since January 1998. Dr. Glimcher is the President and Chief Executive Officer of the Dana-Farber Cancer Institute, the Principal Investigator and Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine, Harvard Medical School. From January 2012 to June 2016, Dr. Glimcher served as the Stephen and Suzanne Weiss Dean of the Weill Cornell Medical College and Provost for Medical Affairs of Cornell University. From 1991 through 2011, Dr. Glimcher served as the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School. Waters Committee Memberships Nominating and Corporate Governance Committee Other Current Public Company Boards Bristol-Myers Squibb Company Former Public Company Directorships Held in the Past Five Years None |
| 2018-03-29 | Dr. Glimcher, 66, has served as a Director of the Company since January 1998. Waters Committee Memberships: Nominating and Corporate Governance Committee. Director Compensation Fiscal Year 2017: $285,440 |
| 2019-04-04 | Dr. Glimcher, 67, has served as a Director of the Company since January 1998. Dr. Glimcher is the President and Chief Executive Officer of the Dana-Farber Cancer Institute. Waters Committee Memberships: Nominating and Corporate Governance Committee, Science and Technology Committee (Chair). Director Compensation Fiscal Year 2018: Laurie H. Glimcher, M.D. Fees Earned or Paid in Cash $70,000, Stock Awards $109,978, Option Awards $109,995, Total $289,973. |
| 2020-04-02 | Laurie H. Glimcher, M.D. President and Chief Executive Officer of the Dana-Farber Cancer Institute Director since 1998 Age: 68 Committees Nominating and Corporate Governance Science and Technology (Chair) ...Dr. Glimcher brings a diversity of technical skills and experience to the Waters Board. ...Director Compensation Fiscal Year 2019 Laurie H. Glimcher, M.D. Fees Earned or Paid in Cash ($): $81,000 Stock Awards ($): $109,863 Option Awards ($): $110,000 Total ($): $300,863. |
Data sourced from SEC filings. Last updated: 2026-02-03